Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Epizyme Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Epizyme Inc, Medical Devices Deals, 2012 to YTD 2018 10
Epizyme Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Epizyme Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Epizyme Enters into Partnership with US Oncology Research 12
Epizyme Enters into Agreement with Genentech 13
Strata Oncology Enters into Agreement with EpiZymev 14
Epizyme Enters into Research Agreement with National Cancer Institute 15
Epizyme Enters into Agreement with Foundation Medicine 16
Epizyme Enters into Agreement with Genentech 17
Epizyme Enters into Agreement with Lymphoma Study Association 18
Licensing Agreements 19
Epizyme Amends Licensing Agreement with Celgene for HMT Inhibitor Programs 19
Equity Offering 21
Epizyme Raises USD86.2 Million in Public Offering of Shares 21
Epizyme Raises USD161 Million in Public Offering of Shares 23
EpiZyme Raises USD1.9 Million in Public Offering of Shares 25
Epizyme Raises USD138 Million in Public Offering of Shares 26
Epizyme Raises USD139 Million in Public Offering of Shares 28
EpiZyme Announces Exercise Of Underwriters Over Allotment Option Of Public Offering Of Shares For US$107.5 Million 30
EpiZyme Completes IPO For US$89 Million 32
Epizyme Inc – Key Competitors 34
Epizyme Inc – Key Employees 35
Epizyme Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Nov 02, 2018: Epizyme reports third quarter 2018 financial results and Tazemetostat progress 37
Aug 02, 2018: Epizyme reports second quarter 2018 financial results and provides business updates 39
May 08, 2018: Epizyme Reports First Quarter 2018 Financial Results and Provides Business Updates 41
Mar 13, 2018: Epizyme Reports Fourth Quarter and Full Year 2017 Financial Results 43
Nov 01, 2017: Epizyme Reports Third Quarter 2017 Operating Results and Company Updates 45
Aug 04, 2017: Epizyme Reports Second Quarter 2017 Financial Results and Clinical and Business Progress 46
May 08, 2017: Epizyme Reports First Quarter 2017 Results and Provides Corporate Update 48
Mar 09, 2017: Epizyme Reports 2016 Financial Results and Provides 2017 Pipeline Goals 49
Corporate Communications 51
Jul 23, 2018: Epizyme names Dr. Shefali Agarwal as Chief Medical Officer 51
Mar 12, 2018: Epizyme Appoints Oncology Industry Leader Michael Giordano, M.D., to its Board of Directors 52
Aug 15, 2017: Epizyme Announces Leadership Transition for Finance Organization 53
Mar 09, 2017: Epizyme President of Research and Chief Scientific Officer, Robert Copeland, Announces Retirement from the Company 54
Feb 07, 2017: Epizyme Elects Kevin Conroy to its Board of Directors 55
Clinical Trials 56
Dec 11, 2017: Epizyme Presents Preclinical Data on Novel G9a Program and Introduces Next Drug Development Candidate at the American Society of Hematology Annual Meeting 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
Epizyme Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Epizyme Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Epizyme Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Epizyme Inc, Medical Devices Deals, 2012 to YTD 2018 10
Epizyme Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Epizyme Enters into Partnership with US Oncology Research 12
Epizyme Enters into Agreement with Genentech 13
Strata Oncology Enters into Agreement with EpiZymev 14
Epizyme Enters into Research Agreement with National Cancer Institute 15
Epizyme Enters into Agreement with Foundation Medicine 16
Epizyme Enters into Agreement with Genentech 17
Epizyme Enters into Agreement with Lymphoma Study Association 18
Epizyme Amends Licensing Agreement with Celgene for HMT Inhibitor Programs 19
Epizyme Raises USD86.2 Million in Public Offering of Shares 21
Epizyme Raises USD161 Million in Public Offering of Shares 23
EpiZyme Raises USD1.9 Million in Public Offering of Shares 25
Epizyme Raises USD138 Million in Public Offering of Shares 26
Epizyme Raises USD139 Million in Public Offering of Shares 28
EpiZyme Announces Exercise Of Underwriters Over Allotment Option Of Public Offering Of Shares For US$107.5 Million 30
EpiZyme Completes IPO For US$89 Million 32
Epizyme Inc, Key Competitors 34
Epizyme Inc, Key Employees 35
Epizyme Inc, Subsidiaries 36
List of Figures
Epizyme Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Epizyme Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Epizyme Inc, Medical Devices Deals, 2012 to YTD 2018 10